Product Suite &
Pharmaceutical Pipeline
Pharmaceutical Pipeline
We are engaged in the development of novel therapeutics to address unmet medical needs in infectious disease and dermatology.
FDA Approval Process
Stage 1 – Discovery
Stage 2 – Manufacture
Stage 3 – Toxicity Trials
Stage 4 – Human Clinical Trials
Stage 5 – FDA Approval
Pharmaceutical Pipeline
We are engaged in the development of novel therapeutics to address unmet medical needs in infectious disease and dermatology.
Pharmaceutical Pipeline
We are engaged in the development of novel therapeutics to address unmet medical needs in infectious disease and dermatology.
*Lead candidate
**Orphan candidate
***CDC Emerging Threat
Product Suite
Market-ready assets include management tools for advanced wound care and dermatitis. Pipeline assets include FleX™ Antimicrobial, an antimicrobial regenerative collagen powder, as well as Xeal® Silicone, a non-adherent, antimicrobial silicone dressing.
